Peps
What is Selank?
Selank is a research peptide discussed for anxiety-related effects. Its small clinical literature needs careful attention to study design and replication.
Biological role or research focus
Anxiety-related peptide research.
A small comparative study is not a complete evidence base for routine anxiety treatment.
Role reference: [A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders]. ↗
Names you may encounter
selank acetate · TP-7
Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.
- Class / identity
- Experimental anxiety-related peptide
- Main research area
- Anxiety and neurobiology research
- Evidence featured
- Small human comparative study
- Source check
- October 4, 2026
Molecular structure
Mechanism & research rationale
The selected human report investigates symptom changes rather than establishing a complete molecular mechanism. Proposed neurobiological explanations should not be mistaken for demonstrated clinical effectiveness.
Research context & status
A small comparison with phenazepam is summarized below. Its abstract leaves important design questions unresolved, and it does not establish a broad routine anxiety-treatment role.
What does the evidence show?
Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.
Small human comparative study · 2014
Anxiety-disorder comparison
[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].
- Population / model
- 60 patients with phobic-anxiety or somatoform disorders.
- Study design
- Selank compared with phenazepam; abstract-level report.
- Main finding
- The authors reported anxiety improvement, tolerability, and quality-of-life findings, including effects persisting a week after treatment.
- Limits & context
- The abstract does not adequately resolve allocation, blinding, effect size, or long-term harms. It is not a placebo-controlled replication or proof of routine effectiveness across anxiety disorders.
Human active-comparator study · 2008
Selank versus medazepam · 2008
What does the earlier anxiety report add?
- Population / model
- 62 patients with generalized anxiety disorder or neurasthenia: 30 received Selank and 32 medazepam.
- Study design
- Psychometric assessments and blood enkephalin measurements; PubMed indexes a randomized trial, but the English abstract does not describe allocation concealment or blinding.
- Main finding
- The authors reported similar anxiety effects between groups, with additional anti-asthenic and psychostimulant findings for Selank.
- How to read it
- Similar observed effects are not a formal demonstration of equivalence or noninferiority.
- Limits & context
- No placebo group or numerical effect estimates are described in the abstract. The Russian-language full article needs qualified review. This does not establish effectiveness for every anxiety disorder or safety with other psychiatric medicines.
Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.
Search additional PubMed records ↗New editorial updates
New source discoveries
Links appear automatically. Unreviewed discoveries are not verified medical findings.
Safety & precautions
Safety evidence & remaining uncertainty
FDA identifies inadequate safety information. A favorable short report cannot rule out interactions, uncommon reactions, or risks of repeated use.
Source: FDA · Peptide compounding safety concerns ↗
This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.
What are people discussing?
Proposed neurochemical explanations
The conversation links these neuropeptides to the host’s experience, then proposes neurotransmitter and growth-factor explanations for Semax. These mechanistic claims need separate study-level verification.
Are the proposed mechanism and meaningful clinical outcome both demonstrated in humans?
Caption excerpt reviewed · Claims not independently verified · 2026-10-04
Original episode: PEPTIDES FOR ANXIETY? |SEMAX & SELANK | Real Bodybuilding Podcast
Watch the source discussions
13 matching video records · 3 with captions indexed.
Across the full library, 30 caption files are indexed from 20,199 inventoried videos. Most transcripts remain unreviewed. Select a thumbnail or timestamp to watch inside PepsRadar. Thumbnail images load from YouTube.
Fouad Abiad Media
PEPTIDES FOR ANXIETY? |SEMAX & SELANK | Real Bodybuilding Podcast ↗
Captions indexed · Automatic matches need review
Fouad Abiad Media
RETATRUTIDE: EVERYTHING YOU NEED TO KNOW | Wes Christensen | Fouad Abiad's Real Bodybuilding Podcast ↗
Captions indexed · Automatic matches need review
Peptide Of The Week
Telehealth vs Research Peptides: The Truth Nobody Tells You | Peptide of the Week Q&A #61 ↗
Captions indexed · Automatic matches need review
Biohackingturkey
30 Günlük Semax ve Selank Deneyi: Bunu Beklemiyordum! ↗
Title match · Captions not indexed
Biohackingturkey
Semax + Selank Kombinasyonu: Bilmeniz Gereken 5 Etki ↗
Title match · Captions not indexed
Dr. Jones, DC
Do you have excess anxiety?! Selank and Semax are powerful nootropic peptides! (Full vid on TikTok) ↗
Title match · Captions not indexed
Sources & supplier listings
Listings are grouped by the vendor’s stated identity. Blends and modified derivatives are labeled separately. Inclusion is not a quality assessment or an endorsement.
N-Acetyl Selank Amidate (20mg)
BioLongevity Labs · Vendor-labeled research use only
$134.97
Listed in stock · Snapshot 2026-10-04
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
SELANK (10 mg)
American Peptides · Vendor-labeled research use only
$65.00
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
SELANK + SEMAX (5 mg / 5 mg)
American Peptides · Vendor-labeled research use only
$70.00
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
Selank (11 mg)
PSPeptides · Vendor-labeled research use only
$32.99
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
Selank+Semax Blend (10 mg - 5/5 mg / 40 mg - 30/10 mg)
PSPeptides · Vendor-labeled research use only
$54.99–$129.99
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
Catalog checked 2026-10-04. Seller listings retain their stated intended use. Shops covered: BioLongevity Labs, BioLongevity Supplements, American Peptides, PSPeptides. This is not a market-wide comparison. Affiliate participation does not determine evidence or editorial coverage.
Questions worth asking
- What specific product, route, and research population does the claim refer to?
- Does the source measure an outcome in people, or only a laboratory marker?
- A small comparative study is not a complete evidence base for routine anxiety treatment.
- What adverse effects, uncertainty, and conflicts of interest does the original source report?
Frequently asked questions
Is the study clearly a blinded placebo-controlled trial?
The available abstract does not establish that. It reports comparison with phenazepam.
Does a small favorable study settle an anxiety-treatment question?
No. Replication, effect size, allocation methods, and longer-term outcomes remain important.
References & editorial record
- FDA · Compounding safety concerns ↗
- PubMed · Small human comparative study · PMID 25176261 ↗
- Selank versus medazepam · 2008 · 2008 ↗
Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation. Video notes specify which excerpts were reviewed; no full transcripts are published.